期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恶性肿瘤继发性血栓性血小板减少性紫癜一例及文献复习

下载PDF
导出
作者 傅爱林 徐海源 沈文香
机构地区 江苏大学附属昆山市第一人民医院血液肿瘤科
出处 《实用临床医学（江西）》 CAS 2007年第2期34-35,共2页 Practical Clinical Medicine
关键词 恶性肿瘤 血栓性血小板减少性紫癜
分类号 R554.6 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献10

  • 1Mayer S A,Aledort L M.Throm Boti Microangiopathy:Differential Diagnosis,Pathoplysiology and the Rapeutic Strategies[J].Mt Sina J Med,2005,72(4):166-175.
  • 2Moake J L.Thrombotic Microangiopathies[J].N.Engk J Med,2002,347(9):589-600.
  • 3Sadler J E,Moake J L,Miyata T,et al.Recent Advances in Thrombotic Thrombocytopenic Purpura[J].Hematology (Am Soc Hematol Educ Program),2004,320(8):407-423.
  • 4Tsai H M,Lian E C.Antibodies to Von Willebrand Factor-cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura[J].N Engl J Med,1998,339(22):1585-1594.
  • 5Dong J F,Moake J L,Nolasco L,et al.ADAMTS-13 Radpdly Cleaves Newly Secreted Ultralarge Von Willebrand Factormultimesrs on the Endothelial Surface Under Flowing Conditions[J].Blood,2002,100(12):4033-4039.
  • 6Raife T J,Lentz S R,A tkinson B S,et al.Factor V Leiden A Genetic Risk Factor for the Thrombotic Microangiopathy in Patients with Normal Von Willebrand Factor-cleaving Protease Activity[J].Blood,2002,99(2):437-442.
  • 7Mandala M,Curigliano G,Bucciatelli P,et al.Factor V Leiden and G20210A Prothrombin Mutation and the Risk of Subclavian Vein Thrombosis in Patients with Breast Cancer and A Central Venous Catheter[J].Ann Oncol,2004,15(4):590.
  • 8Coppo P,Bussel A,Charrier S,et al.High-dose Plasma Infusion Versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/hemolytic-uremic Syndrome[J].Medicine (Baltimore),2003,82(1):27-38.
  • 9王学文.获得性血栓性血小板减少性紫癜治疗学进展[J].中国医师进修杂志（内科版）,2006,29(5):63-65. 被引量：1
  • 10Fakhouri F.Effiency of Curative and Prophylactic Treatment with Rituximab in ADAMTS-13 Deficient TTP:A Study of 11 Cases[J].Blood,2005,106(6):1932-1937.

二级参考文献18

  • 1Alloford SL, Hunt BJ, Rose P, et al. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anemiss. Br J Med,2003,120(3) : 556 - 573.
  • 2Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura, J Am Soc Nephrol, 2003,14(4) : 1072 - 1081
  • 3Matsumoto M, Yagi H, Ishizashi H, et al. The Japanese experience with thromboeytopenie purpura- hemolytic uremic syndrome.Semin Hematol, 2004, 41 (1): 68- 74.
  • 4藤村吉博.TTPとHUS.医学めゅみ.2003,206(1):101-104.
  • 5松本雅则 八木秀男 藤村吉博.VWF—CP／ADAMTS—13[J].臨床血液,2003,44(3):159-159.
  • 6Fontanas S, Kremer Hovinga JA, Studt JD, et al. Plasma therapy in thrombotic thrombocytopenic purpura: Review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS- 13 deficiency. Semin Hematol, 2004, 41 ( 1) :48 - 59.
  • 7Coppo P, Bussel A, Chattier S, et al. High - dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocy-topenic purpura/hemolytic - uremic syndrome. Medicine (Baltimore), 2003, 82(1): 27-38.
  • 8Zeigler ZR, Shadduck RK, Gryn JK, et al. Cryopreeipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apheresis, 2001,16( 1 ) :19 - 22.
  • 9Cardigan R, Allford S, Williamson L. Levels of von Willebrand factor cleaving protease are normal in methylene blué treated fresh frozen plasma. Br J Haematol, 2002, 117 (2) : 253 - 254.
  • 10Rizvi MA, Vesely SK, George JN, et al. Complicatiom of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura- hemolytic uremic syndrome.Transfusion, 2002, 40(8): 896-901.
实用临床医学（江西）
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部